The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
The structure and function of G-protein-coupled receptors
Open accessAbstract
G-protein-coupled receptors (GPCRs) mediate most of our physiological responses to hormones, neurotransmitters and environmental stimulants, and so have great potential as therapeutic targets for a broad spectrum of diseases. They are also fascinating molecules from the perspective of membrane-protein structure and biology. Great progress has been made over the past three decades in understanding diverse GPCRs, from pharmacology to functional characterization in vivo. Recent high-resolution structural studies have provided insights into the molecular mechanisms of GPCR activation and constitutive activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GPR20 belongs to the family of the G-protein-coupled receptors, which participate in intracellular second messenger systems triggered by different hormones and neurotransmitters, and amyloid β.53, 54, 55”
From APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease (2016) · cites this paper as [54]
In the citing paper
“Both theoretical and experimental results do not offer any clear conclusions with respect to the vibrational theory of neurotransmission for adenosine, serotonin and histamine receptors and their related ligands.”
From Quantum effects in the brain: A review (2020) · cites this paper as [115]
In the citing paper
“Understanding the mechanism or mechanisms of ligand-GPCR interaction is particularly important due to the fact that GPCRs are a major drug target associated with one third of all pharmaceuticals 103,115 .”
From Quantum effects in the brain: A review (2020) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H., Kühn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,280
Self-citationBallesteros, J. A., & Weinstein, H. (1995) · Methods in neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 3,001 · cited 1×
“48 (human β 2 AR, with Ballesteros/Weinstein numberin”
Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941 · cited 1×
“GPCRs in vertebrates are commonly divided into five families on the basis of their sequence and structural similarity”
Crystal structure of the human β2 adrenergic G-protein-coupled receptor
Rasmussen, S. G. F., Choi, H., Rosenbaum, D. M., Kobilka, T. S., Thian, F. S., Edwards, P. C., Burghammer, M. C., Ratnala, V. R. P., Sanishvili, R., Fischetti, R. F., et al. (2007) · Nature · doi:10.1038/nature06325 · Cited by 1,935
Self-citationThe 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,786
Léan, A. D., Stadel, J. M., & Lefkowitz, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79672-9 · Cited by 1,606
Structure of a β1-adrenergic G-protein-coupled receptor
Warne, T., Serrano‐Vega, M. J., Baker, J. G., Moukhametzianov, R., Edwards, P. C., Henderson, R. A., Leslie, A. G. W., Tate, C. G., & Schertler, G. F. X. (2008) · Nature · doi:10.1038/nature07101 · Cited by 1,377
GPCR Engineering Yields High-Resolution Structural Insights into β 2 -Adrenergic Receptor Function
Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H., Yao, X.-J., Weis, W. I., Stevens, R. C., et al. (2007) · Science · doi:10.1126/science.1150609 · Cited by 1,335
Self-citationCloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin
Dixon, R. A. F., Kobilka, B. K., Strader, D. J., Benovic, J., Dohlman, H. G., Frielle, T., Bolanowski, M. A., Bennett, C. D., Rands, E., Diehl, R. E., et al. (1986) · Nature · doi:10.1038/321075a0 · Cited by 1,275 · cited 1×
“The clustering of these residues in the cytoplasmic half of the transmembrane bundle reflects the basic conservation of mechanism across GPCRs, a remarkable structural affirmation of a hypothesis made more than 20 years ag”
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 1,002
Expedient Total Synthesis of Small to Medium-Sized Membrane Proteins via Fmoc Chemistry
Zheng, J., Yu, M., Qi, Y., Tang, S., Shen, F., Wang, Z., Xiao, L., Zhang, L., Tian, C., & Liu, L. (2014) · Journal of the American Chemical Society · doi:10.1021/ja500222u · Cited by 180
Mas and Its Related G Protein–Coupled Receptors, Mrgprs
Bäder, M., Alenina, N. V., Andrade-Navarro, M. A., & Santos, R. A. S. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008136 · Cited by 179
“…which may be involved in blocking agonistindependent activity: the Cys-Cys bridge from transmembrane domain (TM) 3 to extracellular domain 2 (Knospe et al., 2013; Prokop et al., 2013) and the so-called “ionic-lock” from the amino acids E/DRY in TM3 to a glutamate in TM6 (Rosenbaum et al., 2009).”
BackgroundModulation of Bitter Taste Perception by a Small Molecule hTAS2R Antagonist
Slack, J. P., Brockhoff, A., Batram, C., Menzel, S., Sonnabend, C., Born, S., Galindo, M. M., Kohl, S., Thalmann, S., Halip, L., et al. (2010) · Current Biology · doi:10.1016/j.cub.2010.04.043 · Cited by 177
A review of the molecular mechanisms of acaricide resistance in mites and ticks
Rouck, S. D., İnak, E., Dermauw, W., & Leeuwen, T. V. (2023) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2023.103981 · Cited by 177
GPCRs: Emerging anti-cancer drug targets
Nieto, A., & McDonald, P. H. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.09.005 · Cited by 173
Jafurulla, M., Tiwari, S., & Chattopadhyay, A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.031 · Cited by 174
“The G-protein coupled receptor (GPCR) superfamily is the largest and most diverse protein family in mammals, involved in signal transduction across membranes [8].”
BackgroundXia, J., Li, T., Lu, C., & Xu, H. (2018) · Macromolecules · doi:10.1021/acs.macromol.8b01597 · Cited by 175
Effects of endocytosis on receptor-mediated signaling
Irannejad, R., Tsvetanova, N. G., Lobingier, B. T., & von Zastrow, M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.05.005 · Cited by 178
Miller, J. L., Nehmé, R., Warne, T., Edwards, P. C., Schertler, G. F. X., Leslie, A. G. W., & Tate, C. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092727 · Cited by 169
Mapping Interactions of Microbial Metabolites with Human G-Protein-Coupled Receptors
Colosimo, D. A., Kohn, J. A., Luo, P. M., Piscotta, F. J., Han, S. M., Pickard, A. J., Rao, A., Cross, J. R., Cohen, L. J., & Brady, S. F. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.07.002 · Cited by 176
“Many of these same proteins bind endogenous signaling molecules that regulate a wide range of physiological responses (Rosenbaum et al., 2009).”
BackgroundGPCR mediated regulation of synaptic transmission
Betke, K. M., Wells, C. A., & Hamm, H. E. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.01.009 · Cited by 172
“conformations for interaction with particular effector molecules (Rosenbaum et al., 2009).”
BackgroundEngineering G protein-coupled receptors to facilitate their structure determination
Tate, C. G., & Schertler, G. F. X. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.07.004 · Cited by 174
G protein-coupled receptors: mutations and endocrine diseases
Vassart, G., & Costagliola, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.20 · Cited by 169
Molecular complexity and fragment-based drug discovery: ten years on
Leach, A. R., & Hann, M. M. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.05.008 · Cited by 172
Dimerization in GPCR mobility and signaling
Lohse, M. J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.10.007 · Cited by 172
Emerging mechanistic understanding of cilia function in cellular signalling
Hilgendorf, K. I., Myers, B. R., & Reiter, J. F. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00698-5 · Cited by 171
“131) (Fig.”
Hedger, G., & Sansom, M. S. P. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.02.037 · Cited by 164
Super-Resolution Microscopy: Shedding Light on the Cellular Plasma Membrane
Stone, M. B., Shelby, S. A., & Veatch, S. L. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00716 · Cited by 168
DeMaria, S., & Ngai, J. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201008163 · Cited by 176
“…inactivated mutant receptor used in the abovementioned study (Imai et al., 2006) retains a level of intrinsic activity—reflecting the receptor’s equilibrium between inactive and active states in the absence of bound agonist (Rosenbaum et al., 2009)—to re press expression from other OR gene loci.”
Organ-Protective Effects and the Underlying Mechanism of Dexmedetomidine
Bao, N. T. Y., & Tang, B. (2020) · Mediators of Inflammation · doi:10.1155/2020/6136105 · Cited by 163
Rittschof, C. C., Bukhari, S. A., Sloofman, L. G., Troy, J. M., Caetano-Anollés, D., Cash-Ahmed, A. C., Kent, M., Lu, X., Sanogo, Y. O., Weisner, P. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420369111 · Cited by 160
Mayendraraj, A., ROSENKILDE, M. M., & Gasbjerg, L. S. (2022) · Peptides · doi:10.1016/j.peptides.2022.170749 · Cited by 165
What have we learned about GPER function in physiology and disease from knockout mice
Prossnitz, E. R., & Hathaway, H. J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.06.014 · Cited by 157
Coagulation and non‐coagulation effects of thrombin
Posma, J., Posthuma, J. J., & Spronk, H. M. H. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13441 · Cited by 157
Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Reeves, K. C., Shah, N., Muñoz, B., & Atwood, B. K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.919773 · Cited by 156
G Protein-coupled Estrogen Receptor Protects from Atherosclerosis
Meyer, M. R., Fredette, N. C., Howard, T. A., Hu, C., Ramesh, C., Daniel, C., Amann, K., Arterburn, J. B., Barton, M., & Prossnitz, E. R. (2014) · Scientific Reports · doi:10.1038/srep07564 · Cited by 156
Carpenter, B., & Tate, C. G. (2016) · Protein Engineering Design and Selection · doi:10.1093/protein/gzw049 · Cited by 161
“G protein-coupled receptors (GPCRs) modulate cytoplasmic signalling, through heterotrimeric G proteins and β-arrestins, in response to extracellular stimuli, such as hormones and neurotransmitters (Rosenbaum et al., 2009).”
BackgroundLayer-by-layer cell membrane assembly
Matosevic, S., & Paegel, B. M. (2013) · Nature Chemistry · doi:10.1038/nchem.1765 · Cited by 155
Pathway and Mechanism of Drug Binding to G-Protein-Coupled Receptors
Dror, R. O., Pan, A. C., Arlow, D. H., Borhani, D. W., Maragakis, P., Shan, Y., Xu, H., & Shaw, D. E. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2011.11.2241 · Cited by 155
Activation of GPR4 by Acidosis Increases Endothelial Cell Adhesion through the cAMP/Epac Pathway
Chen, A., Dong, L., Leffler, N. R., Asch, A. S., Witte, O. N., & Yang, L. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027586 · Cited by 151
Shrivastava, S. K., Pucadyil, T. J., Paila, Y. D., Ganguly, S., & Chattopadhyay, A. (2010) · Biochemistry · doi:10.1021/bi100276b · Cited by 154
Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
Xiao, Q., Wang, L., Supekar, S., Shen, T., Liu, H., Ye, F., Huang, J., Fan, H., Wei, Z., & Zhang, C. (2020) · Nature Communications · doi:10.1038/s41467-020-19249-z · Cited by 166
Mori, T., Miyashita, N., Im, W., Feig, M., & Sugita, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.12.032 · Cited by 150
Prasanna, X., Chattopadhyay, A., & Sengupta, D. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.02.002 · Cited by 148
Light-inducible receptor tyrosine kinases that regulate neurotrophin signalling
Chang, K.-Y., Woo, D., Jung, H., Lee, S., Kim, S., Won, J., Kyung, T., Park, H., Kim, N., Yang, H. W., et al. (2014) · Nature Communications · doi:10.1038/ncomms5057 · Cited by 150
Holst, B., Nygaard, R., Valentin-Hansen, L., Bach, A., Engelstoft, M. S., Petersen, P. S., Frimurer, T. M., & Schwartz, T. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064725 · Cited by 148
Lipidic phase membrane protein serial femtosecond crystallography
Johansson, L. C., Arnlund, D., White, T. A., Katona, G., DePonte, D. P., Weierstall, U., Doak, R. B., Shoeman, R. L., Lomb, L., Malmerberg, E., et al. (2012) · Nature Methods · doi:10.1038/nmeth.1867 · Cited by 148
Greene, T. A., Alarcon, S., Thomas, A. A., Berdougo, E., Doranz, B. J., Breslin, P. A. S., & Rucker, J. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020123 · Cited by 147
G protein-coupled receptor kinases as therapeutic targets in the heart
Pfleger, J. M., Gresham, K. S., & Koch, W. J. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0220-3 · Cited by 154
G-protein-coupled receptors, Hedgehog signaling and primary cilia
Mukhopadhyay, S., & Rohatgi, R. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.05.002 · Cited by 142
The Dynamic Process of b 2 -Adrenergic Receptor Activation
Nygaard, R., Zou, Y., Dror, R. O., Mildorf, T. J., Arlow, D. H., Manglik, A., Pan, A. C., Liu, C. W., Bokoch, M. P., Thian, F. S., et al. (2013) · Cited by 146
Self-citationMicroscopic rotary mechanism of ion translocation in the Fo complex of ATP synthases
Pogoryelov, D., Krah, A., Langer, J. D., Yıldız, Ö., Faraldo‐Gómez, J. D., & Meier, T. W. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.457 · Cited by 145
Nakashima, A., Takeuchi, H., Imai, T., Saito, H., Kiyonari, H., Abe, T., Chen, M., Weinstein, L. S., Yu, C. R., Storm, D. R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.033 · Cited by 143
“However, recent studies of crystal structures and molecular dynamics have revealed the inner workings of various GPCRs (Nygaard et al., 2013; Rasmussen et al., 2011a, 2011b; Rosenbaum et al., 2009).”
Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses
Hoffman, B. U., Baba, Y., Griffith, T. N., Mosharov, E. V., Woo, S., Roybal, D., Karsenty, G., Patapoutian, A., Sulzer, D., & Lumpkin, E. A. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.034 · Cited by 142
G Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers
Arang, N., & Gutkind, J. S. (2020) · FEBS Letters · doi:10.1002/1873-3468.14017 · Cited by 151
Heteromeric MT 1 /MT 2 Melatonin Receptors Modulate Photoreceptor Function
Baba, K., Benleulmi‐Chaachoua, A., Journé, A., Kamal, M. T., Guillaume, J., Dussaud, S., Gbahou, F., Yettou, K., Liu, C., Contreras‐Alcantara, S., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004302 · Cited by 145
Molecular dynamics simulations of GPCR–cholesterol interaction: An emerging paradigm
Sengupta, D., & Chattopadhyay, A. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.03.018 · Cited by 144
Hennen, S., Wang, H., Peters, L., Merten, N., Simon, K., Spinrath, A., Blättermann, S., Akkari, R., Schrage, R., Schröder, R. J., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004350 · Cited by 146
Gahbauer, S., & Böckmann, R. A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00494 · Cited by 150
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
Cabral-Marques, O., Halpert, G., Schimke, L. F., Ostrinski, Y., Vojdani, A., Baiocchi, G. C., Freire, P. P., Filgueiras, I. S., Zyskind, I., Lattin, M. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28905-5 · Cited by 144
EGF receptor activation by GPCRs: An universal pathway reveals different versions
Liebmann, C. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.008 · Cited by 143
Yagi, H., Tan, W., Dillenburg-Pilla, P., Armando, S., Amornphimoltham, P., Simaan, M., Weigert, R., Molinolo, A., Bouvier, M., & Gutkind, J. S. (2011) · Science Signaling · doi:10.1126/scisignal.2002221 · Cited by 144
“Structural information for many GPCRs suggests that activated members of this family of receptors may adopt multiple conformations (52), which could, in turn, selectively engage distinct downstream signaling pathways.”
BackgroundIdentification of Cholesterol Binding Sites in the Serotonin1A Receptor
Sengupta, D., & Chattopadhyay, A. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp309888u · Cited by 141
Moreno, J. L., Muguruza, C., Umali, A., Mortillo, S., Holloway, T. D., Pilar-Cuéllar, F., Mocci, G., Seto, J., Callado, L. F., Neve, R. L., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.413161 · Cited by 142
Succinate induces skeletal muscle fiber remodeling via SUCNR1 signaling
Wang, T., Xu, Y., Yuan, Y., Xu, P., Zhang, C., Li, F., Wang, L., Yin, C., Zhang, L., Cai, X., et al. (2019) · EMBO Reports · doi:10.15252/embr.201947892 · Cited by 139
Genetics of ankylosing spondylitis
Robinson, P. C., & Brown, M. A. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.06.013 · Cited by 142
Chemogenetic Tools for Causal Cellular and Neuronal Biology
Atasoy, D., & Sternson, S. M. (2017) · Physiological Reviews · doi:10.1152/physrev.00009.2017 · Cited by 137
Structure determination of GPCRs: cryo-EM compared with X-ray crystallography
García‐Nafría, J., & Tate, C. G. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210431 · Cited by 149
Differential Signaling by Splice Variants of the Human Free Fatty Acid Receptor GPR120
Watson, S., Brown, A., & Holliday, N. D. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.077388 · Cited by 142
“For rhodopsin-like GPCRs, ICL3 is a critical cytoplasmic element of the receptor involved in both G protein and -arrestin recognition (Gurevich and Gurevich, 2006; Rosenbaum et al., 2009), and ICL3 insertion in GPR120L could result in significant changes in receptor signaling properties.”
BackgroundHudson, B. D., Tikhonova, I. G., Pandey, S. K., Ulven, T., & Milligan, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.396259 · Cited by 136
Adhesion G Protein-Coupled Receptors: Signaling, Pharmacology, and Mechanisms of Activation
Paavola, K. J., & Hall, R. A. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080309 · Cited by 134
“Because mutations to certain adhesion GPCRs cause human disease and because many members of this receptor family exhibit highly discrete distribution patterns in different tissues, the adhesion GPCRs represent a class of potentially important drug targets that have not yet been exploited.”
BackgroundSystems-level identification of PKA-dependent signaling in epithelial cells
Isobe, K., Jung, H. J., Yang, C., Claxton, J. S., Sandoval, P. C., Burg, M. B., Raghuram, V., & Knepper, M. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1709123114 · Cited by 134
Regulation of neuronal communication by G protein‐coupled receptors
Huang, Y., & Thathiah, A. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.007 · Cited by 139
Structure, function and drug discovery of GPCR signaling
Cheng, L., Xia, F., Li, Z., Shen, C., Yang, Z., Hou, H., Sun, S., Feng, Y., Yong, X., Tian, X., et al. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00156-w · Cited by 138
“Upon activation, a serial conserved “micro switch” motif, including CWxP, Na + pocket, PIF, DRY and NPxxY motif, is observed to exhibit conformation arrangement in GPCR [20–22].”
BackgroundMoorlag, S. J. C. F. M., Folkman, L., ter Horst, R., Krausgruber, T., Barreca, D., Schuster, L. C., Fife, V. E. R., Matzaraki, V., Li, W., Reichl, S., et al. (2024) · Immunity · doi:10.1016/j.immuni.2023.12.005 · Cited by 145
How functional foods play critical roles in human health
Pang, G., Xie, J., Chen, Q., & Zhi-he, H. (2012) · Food Science and Human Wellness · doi:10.1016/j.fshw.2012.10.001 · Cited by 134
Zhang, H., Bi, G., Li, X., Li, J., Qu, H., Zhang, S.-J., Li, C., Onaivi, E. S., Gardner, E. L., Xi, Z., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.297 · Cited by 134
Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis
Hov, J. R., Keitel, V., Laerdahl, J. K., Spomer, L., Ellinghaus, E., ElSharawy, A., Melum, E., Boberg, K. M., Manke, T., Balschun, T. C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012403 · Cited by 137
Novel Insights on Thyroid-Stimulating Hormone Receptor Signal Transduction
Kleinau, G., Neumann, S., Grüters, A., Krude, H., & Biebermann, H. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1072 · Cited by 129
Distribution and function of the muscarinic receptor subtypes in the cardiovascular system
Saternos, H. C., Almarghalani, D. A., Gibson, H., Meqdad, M. A., Antypas, R. B., Lingireddy, A., & AbouAlaiwi, W. A. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00062.2017 · Cited by 128
Molecular basis for negative regulation of the glucagon receptor
Koth, C. M., Murray, J. M., Mukund, S., Madjidi, A., Minn, A. H., Clarke, H. J., Wong, T., Chiang, V., Luis, E., Estevez, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206734109 · Cited by 128
Waters, S., Gilliham, M., & Hrmová, M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14047660 · Cited by 126
Tellurium-Containing Polymer Micelles: Competitive-Ligand-Regulated Coordination Responsive Systems
Cao, W., Gu, Y., Meineck, M., Li, T., & Xu, H. (2014) · Journal of the American Chemical Society · doi:10.1021/ja500939m · Cited by 126
Free energy of WALP23 dimer association in DMPC, DPPC, and DOPC bilayers
Castillo, N., Monticelli, L., Barnoud, J., & Tieleman, D. P. (2013) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2013.02.001 · Cited by 125
Ligand–receptor interaction platforms and their applications for drug discovery
Ye, F. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.715631 · Cited by 130
A crystal clear solution for determining G-protein-coupled receptor structures
Tate, C. G. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.06.003 · Cited by 133
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
Moreno, E., Andradas, C., Medrano, M., Caffarel, M. M., Pérez-Gómez, E., Blasco-Benito, S., Gómez‐Cañas, M., Pazos, M. R., Irving, A. J., Lluı́s, C., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.561761 · Cited by 120
Membrane Driven Spatial Organization of GPCRs
Mondal, S., Johnston, J. M., Wang, H., Khelashvili, G., Filizola, M., & Weinstein, H. (2013) · Scientific Reports · doi:10.1038/srep02909 · Cited by 117
“Brookhaven National Lab, (3) the Scientific Computing Facility at Icahn School of Medicine”
BackgroundMolecular basis for high-affinity agonist binding in GPCRs
Warne, T., Edwards, P. C., Dore, A. S., Leslie, A. G. W., & Tate, C. G. (2019) · Science · doi:10.1126/science.aau5595 · Cited by 117
Noradrenergic targets for the treatment of alcohol use disorder
Haass-Koffler, C. L., Swift, R. M., & Leggio, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4843-6 · Cited by 117
MacDonald, E. A., Rose, R. A., & Quinn, T. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00170 · Cited by 130
“In general, these substances bind to a GPCR, causing a conformational change in its cytoplasmic domains, which activates its subunits (G α and G βγ ) (Oldham and Hamm, 2008; Rosenbaum et al., 2009; Zhang et al., 2015).”
BackgroundRational design of dualsteric GPCR ligands: quests and promise
Mohr, K., Tränkle, C., Kostenis, E., Barocelli, E., Amici, M. D., & Holzgrabe, U. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00601.x · Cited by 117
Bacteriorhodopsin: Would the real structural intermediates please stand up?
Wickstrand, C., Dods, R. H., Royant, A., & Neutze, R. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.05.021 · Cited by 117
GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Yang, L., Chen, G., Mohanty, S., Scott, G., Fazal, F., Rahman, A., Begum, S., Hynes, R. O., & Xu, L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4543 · Cited by 116
Functionally Important Aromatic–Aromatic and Sulfur−π Interactions in the D2 Dopamine Receptor
Daeffler, K. N.-M., Lester, H. A., & Dougherty, D. A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304560x · Cited by 115
Labeling and Single-Molecule Methods To Monitor G Protein-Coupled Receptor Dynamics
Tian, H., Fürstenberg, A., & Huber, T. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00084 · Cited by 114
Moreno, J. L., Miranda-Azpiazu, P., García‐Bea, A., Younkin, J., Cui, M., Kozlenkov, A., Ben-Ezra, A., Voloudakis, G., Fakira, A. K., Baki, L., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aab0467 · Cited by 115
APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease
Vélez, J. I., Lopera, F., Sepulveda-Falla, D., Patel, H. R., Johar, A. S., Chuah, A., Tobón, C., Rivera, D., Villegas, A., Cai, Y., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.177 · Cited by 111
Basic amino-acid side chains regulate transmembrane integrin signalling
Kim, C., Schmidt, T. H., Cho, E., Ye, F., Ulmer, T. S., & Ginsberg, M. H. (2011) · Nature · doi:10.1038/nature10697 · Cited by 113
Multiple Switches in G Protein-Coupled Receptor Activation
Ahuja, S., & Smith, S. O. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.003 · Cited by 112
Engineering cell sensing and responses using a GPCR-coupled CRISPR-Cas system
Kipniss, N. H., Dingal, P. C. D. P., Abbott, T. R., Gao, Y., Wang, H., Dominguez, A. A., Labanieh, L., & Qi, L. S. (2017) · Nature Communications · doi:10.1038/s41467-017-02075-1 · Cited by 113
Ni, D., Lu, S., & Zhang, J. (2019) · Medicinal Research Reviews · doi:10.1002/med.21585 · Cited by 116
“GPCRs are a class of membrane proteins that lie at crucial nexuses of intracellular signaling networks.(159) G proteins are key effectors of GPCRs and consist of α‐ and βγ‐subunits.”
BackgroundRediger, A., Piechowski, C. L., Yi, C., Tarnow, P., Strotmann, R., Grüters, A., Krude, H., Schöneberg, T., Tschöp, M. H., Kleinau, G., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.287607 · Cited by 113
Engineering therapeutic antibodies targeting G-protein–coupled receptors
Jo, M., & Jung, S. T. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.105 · Cited by 112
Clark, A. J., Negron, C., Hauser, K., Sun, M., Wang, L., Abel, R., & Friesner, R. A. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.003 · Cited by 91
“Protein–protein binding plays a critical role in a wide variety of biological processes, including antibody– antigen binding [1], gamma protein coupled receptor signaling [2], assembly of key molecular machines [3], and cell–cell recognition events (e.”
BackgroundKarpenko, J., Collot, M., Richert, L., Valencia, C., Villa, P., Mély, Y., Hibert, M., Bonnet, D., & Klymchenko, A. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5111267 · Cited by 110
Breunig, M., Merkle, J., Wagner, M., Melzer, M. K., Barth, T. F. E., Engleitner, T., Krumm, J., Wiedenmann, S., Cohrs, C. M., Perkhofer, L., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.03.005 · Cited by 115
Su, X., Xu, Y., Fox, G. C., Xiang, J., Kwakwa, K. A., Davis, J. L., Belle, J. I., Lee, W., Wong, W., Fontana, F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145296 · Cited by 109
Human Adenosine A2A Receptor: Molecular Mechanism of Ligand Binding and Activation
Carpenter, B., & Lebon, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00898 · Cited by 110
A guide to membrane protein X‐ray crystallography
Kermani, A. A. (2020) · FEBS Journal · doi:10.1111/febs.15676 · Cited by 125
Metadata
- Authors
- Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K.
- Affiliations
- Stanford Medicine (US)
- Venue
- Nature
- Published
- 2009-05
- Volume
- 459
- Issue
- 7245
- Pages
- 356-363
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3967846
- OpenAlex
- W1988097700
- Cited by
- 2,534
- References
- 73
- Citations by year
- 2026: 108 · 2025: 171 · 2024: 175 · 2023: 140 · 2022: 196 · 2021: 177 · 2020: 150 · 2019: 172 · 2018: 122 · 2017: 136 · 2016: 132 · 2015: 120 · 2014: 133 · 2013: 135 · 2012: 146
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Lundbeckfonden (R19-2008-2113)
- National Institute of General Medical Sciences (F32GM082028, R01GM083118)
- National Institute of Neurological Disorders and Stroke (R01NS28471, R01NS028471)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- G protein-coupled receptors, GPCR structure, GPCR activation, constitutive activity, membrane protein structure, therapeutic target, hormone signaling, neurotransmitter signaling
- MeSH terms
- Animals, Cytoplasm, Humans, Protein Conformation, Signal Transduction, Conserved Sequence, Receptors, G-Protein-Coupled, Opsins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review